Evidence map›Paper›PMID 42413100›Full record

Observational studyBiomedica : revista del Instituto Nacional de Salud2026

Respiratory infectious diseases in intensive care units’ patients during 2024, in two hospitals in Guayaquil, Ecuador

Francisco Sánchez-Amador, Miguel Merejildo, Luis Solórzano, César Bedoya, Fred Luzuriaga, Joselyne Alvarado, Marcela Miranda, Xavier Alvarado

Abstract readObservational StudyMulticenter StudyEnglish Abstract
In one paragraph

Observational study in Biomedica : revista del Instituto Nacional de Salud, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Francisco Sánchez-AmadorLaboratorio de Biología Molecular, Hospital Luis Vernaza, Guayaquil, Ecuador.ORCID 0000-0003-3566-6964
Miguel MerejildoLaboratorio de Microbiología, Hospital Luis Vernaza, Guayaquil, Ecuador.ORCID 0000-0001-5187-8372
Luis SolórzanoCentro de Referencia Nacional de Parasitología, Instituto Nacional en Investigación de Salud Pública "Leopolodo Izquieta Pérez", Guayaquil, Ecuador; Laboratorio Clínico, Hospital Luis Vernaza, Guayaquil, Ecuador.ORCID 0000-0002-9758-6663
César BedoyaLaboratorio de Biología Molecular, Hospital Luis Vernaza, Guayaquil, Ecuador; Escuela de Posgrado en Salud, UEES, Guayaquil, Ecuador.ORCID 0000-0003-0448-8608
Fred LuzuriagaLaboratorio Clínico, Hospital Luis Vernaza, Guayaquil, Ecuador.ORCID 0009-0002-2402-4050
Joselyne AlvaradoLaboratorio de Biología Molecular, Hospital Roberto Gilbert, Guayaquil, Ecuador.ORCID 0009-0006-8870-5567
Marcela MirandaLaboratorio de Microbiología, Hospital Roberto Gilbert, Guayaquil, Ecuador.ORCID 0000-0002-9701-100X
Xavier AlvaradoLaboratorio de Microbiología, Hospital Luis Vernaza, Guayaquil, Ecuador.ORCID 0009-0005-5942-9762

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction. Viral, bacterial, and fungal infections represent a major health concern, contributing significantly to increased morbidity and mortality in respiratory diseases. Objective. To characterize respiratory infections and their etiological agents in patients admitted to intensive care units during the first six months of 2024. Materials and methods. An observational, cross-sectional, prospective study was conducted in two hospitals between January 1st. and June 30th., 2024. Clinical and microbiological data were collected (dates, age, sex, type of sample, results, and diagnoses) and analyzed using IBM SPSS™ Statistics 27.0. Results. Of the 56 patients admitted, 35 presented respiratory infections, predominantly in females, with a mean age of 49 years. The following agents were identified: rhinovirus/enterovirus, influenza A, coronavirus, parainfluenza, and respiratory syncytial virus. Among the most frequent bacteria found were: Klebsiella pneumoniae, Acinetobacter baumannii, Staphylococcus aureus, Pseudomonas aeruginosa, Haemophilus influenzae, Enterobacter cloacae, Escherichia coli, Proteus spp., Stenotrophomonas maltophilia, Serratia marcescens, Streptococcus agalactiae and S. pneumoniae. Bacterial resistance genes such as CTX-M, KPC, mecA/mecC, and MREJ, NDM, Oxa48-like, and VIM were also detected. In the case of fungal infections, Candida albicans and Candida glabrata were isolated. Most patients with respiratory illness progressed to hospital-acquired pneumonia. Conclusion. During the study period, respiratory infections in the intensive care units were mainly associated with bacterial pathogens, with a high frequency of hospital-acquired pneumonia and the detection of antimicrobial resistance genes.

Indexed as

Cross InfectionIntensive Care UnitsRespiratory Tract InfectionsCross-Sectional StudiesEcuadorFemaleHumansMaleMiddle AgedProspective Studiescoinfecciónenfermedades respiratoriasenfermedades transmisiblesindicadores de morbimortalidadneumonía

Identifiers

PMID42413100
PMCPMC13456538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.